Facebook
Twitter
LinkedIn
Forward
Managing Opioid Risk on the Front Lines: Focus on Active Military Service Members and Veterans – Patient Counseling on Safe Opioid Use
The Managing Opioid Risk on the Front Lines: Focus on Active Military Service Members and Veterans initiative is designed to reach health care professionals (HCPs) involved in the management of patients with pain and licensed to practice in the United States and its territories—particularly those professionals with a Drug Enforcement Agency (DEA) registration to prescribe Schedule II and III drugs. This includes, but is not limited to, physicians in the primary care (including OB/GYNs), pain management, anesthesiology, oncology/hematology, surgery, neurology, psychiatry, and emergency department settings; advanced practitioners, such as nurse practitioners and physician assistants; clinicians working with underserved high-risk populations, such as military veterans; and, members of nonprescriber disciplines involved in the management of pain, such as pharmacists and nurses. All participants will be identified and tracked as either having a DEA registration for prescribing Schedule II and III drugs or not having a registration.
Target Audience
This initiative is designed to educate health care providers involved in the management of patients with pain, including but not limited to physicians in primary care, pain management, anesthesiology, surgery, oncology, hematology-oncology, emergency medicine, and psychiatry; physicians who treat high-risk populations, such as veterans and active service members; advanced practitioners, nurse practitioners, physician assistants, and nurses; and pharmacists.
Learning Objectives
Upon completion of the educational activity, participants should be able to:
- Demonstrate familiarity with key messages around safe opioid-taking practices that should be communicated to patients
- Describe relevant scientific concepts to patients using appropriate language and tone
- Assess the utility of patient-prescriber agreements and other documentation in the patient record
Additional Information
Charles E. Argoff, MD
Professor of Neurology
Albany Medical Center
Albany, New York
Dr. Argoff discloses the following relevant financial relationships:
Speakers’ Bureaus: Allergan plc, Amgen Inc., Biohaven Pharmaceutical, Eli Lilly and Company, Flowonix Medical, Novartis, Teva Pharmaceutical Industries Ltd
Stock: Pfizer Inc., Trevena Inc.
Yvonne M. D’Arcy, MS, APRN-C, CNS
Pain Management & Palliative Care Nurse Practitioner
Suburban Hospital-Johns Hopkins Medicine
Bethesda, Maryland
Ms. D’Arcy discloses the following relevant financial relationships:
Speakers’ Bureau: Salix Pharmaceuticals
Royalty: Springer Publishing
Independent Reviewer
Evelyn L. Lewis, MD, MA, FAAFP, DABDA
Chair
Warrior Centric Healthcare Foundation
Rockville, Maryland
Dr. Lewis has nothing to disclose.
Lynn Webster MD, FACPM, FASAM
Vice President of Scientific Affairs
PRA Healthsciences
Salt Lake City, Utah
Dr. Webster discloses the following relevant financial relationships:
Consultant: Daiichi Sankyo, Insys, Mallinckrodt, Merck, Pain Therapeutics, Pfizer, Shionogi, Teva, Trevena, Vallon
Advisory Boards: BDSI, Ensysce Biosciences, Mallinckrodt, Pfizer, Trevena
Disclosure of Conflicts of Interest Policy
It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with commercial interests whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are resolved by AKH prior to accreditation of the activity and may include any of or combination of the following: attestation to non-commercial content; notification of independent and certified CME/CE expectations; referral to National Author Initiative training; restriction of topic area or content; restriction to discussion of science only; amendment of content to eliminate discussion of device or technique; use of other author for discussion of recommendations; independent review against criteria ensuring evidence support recommendation; moderator review; and peer review.
Accredited Provider Disclosure
AKH staff, planners, and reviewers have no relevant financial relationships to disclose.
Publishing Staff Disclosures
Warrior Centric Healthcare Foundation staff and planners have no relevant financial relationships to disclose.
Reviewer Disclosures
Dorothy Caputo, MA, BSN, RN, Lead Nurse Planner: has no financial relationships with pharmaceutical or medical product manufacturers.
Bernadette Makar, MSN, APRN-BC, NP-C, Nurse Planner: has no financial relationships with pharmaceutical or medical product manufacturers.
Dorothy Duffy, PharmD, Pharmacy Reviewer discloses no financial relationships with pharmaceutical or medical product manufacturers.
Disclosure of Unlabeled Use
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
CME/CE credit provided by AKH Inc., Advancing Knowledge in Healthcare. This activity is jointly provided by AKH Inc., Advancing Knowledge in Healthcare and Warrior Centric Healthcare Foundation.
AMA PRA Category 1 Credits TM
Accreditation Statement
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AKH Inc., Advancing Knowledge in Healthcare and Warrior Centric Healthcare Foundation. AKH Inc., Advancing Knowledge in Healthcare is accredited by the ACCME to provide continuing medical education for physicians.
Designation Statement
AKH Inc., Advancing Knowledge in Healthcare designates this enduring activity for a maximum of 0.5 AMA PRA Category 1 Credits TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physician Assistants
NCCPA accepts AMA PRA Category 1 Credit(s)™ from organizations accredited by ACCME.
ANCC Contact Hour(s)
Accreditation Statement
AKH Inc., Advancing Knowledge in Healthcare is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
Designation Statement
This activity is awarded 0.5 contact hour.
AANP Contact Hour(s)
Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation Standards of the American Association of Nurse Practitioners (AANP) through the joint providership of AKH Inc., Advancing Knowledge in Healthcare and Warrior Centric Healthcare Foundation.
AKH Inc., Advancing Knowledge in Healthcare is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider Number: 030803.
Designation Statement
This activity is approved for 0.5 contact hour which includes 0.5 hour of pharmacology. Activity ID 22034-6
This activity was planned in accordance with AANP Accreditation Standards and Policies..
CE for Pharmacists
Accreditation Statement
AKH Inc., Advancing Knowledge in Healthcare is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Designation Statement
AKH Inc., Advancing Knowledge in Healthcare approves this knowledge-based activity for 0.5 contact hour (0.05 CEU). UAN 0077-9999-20-014-H08-P. Initial release date: May 29, 2020.
Available Credit
- 0.50 AMA PRA Category 1 Credit™
- 0.50 ANCC
This course is offered through MyCME. To take this course you will be redirected to MyCME's website. You must have an account with MyCME in order to complete this activity.
Mocingbird continues to work with our CME partner network to provide courses directly to you. We appreciate your patience as we work toward that goal!